Perseus Proteomics Inc. (TYO:4882)
Japan · Delayed Price · Currency is JPY 232.00
-6.00 (-2.52%)
Apr 17, 2026, 3:30 PM JST
Perseus Proteomics Market Cap
Perseus Proteomics has a market cap or net worth of 3.58 billion as of April 17, 2026. Its market cap has decreased by -74.77% in one year.
Market Cap
3.58B
Enterprise Value
2.35B
Revenue
140.41M
Ranking
n/a
PE Ratio
n/a
Stock Price
232.00
Market Cap Chart
Since June 22, 2021, Perseus Proteomics's market cap has decreased from 10.12B to 3.58B, a decrease of -64.61%. That is a compound annual growth rate of -19.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 3.58B | 8.41% |
| Dec 30, 2025 | 3.30B | -60.12% |
| Dec 30, 2024 | 8.28B | 13.70% |
| Dec 29, 2023 | 7.29B | 97.33% |
| Dec 30, 2022 | 3.69B | -20.91% |
| Dec 30, 2021 | 4.67B | -53.87% |
| Jun 22, 2021 | 10.12B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 14.02T |
| Otsuka Holdings | 5.51T |
| Daiichi Sankyo Company | 5.01T |
| Astellas Pharma | 4.52T |
| Kyowa Kirin | 1.31T |
| Ono Pharmaceutical | 1.16T |
| Santen Pharmaceutical | 579.01B |
| JCR Pharmaceuticals | 69.41B |